The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
New study provides evidence that the use of antiretroviral therapy alters the formation or stabilization of HIV latent reservoirs.
The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.
Understanding which molecules HIV needs in order to leave a cell and multiply is a crucial prerequisite for investigating how the spread can be prevented.
The funding is awarded to health departments representing 57 geographic areas to expand treatment and prevention efforts for HIV/AIDS.
Community Pharmacy Consultant Bruce Kneeland talks with independent pharmacy owner Teresa Dickinson, RPh, discuss compounding at Melrose Pharmacy in Phoenix, Arizona.
Doravirine (Pifeltro, Merck) and doravirine/lamivudine/tenofovir/disoproxil fumarate (Delstrigo) were initially approved for the treatment of HIV in adults with no prior antiretroviral history.
An autopsy-based study examined long-term trends in HIV-related mortality among individuals living with the disease in New York City.
New and emerging strategies in the management of HIV
Top news of the day from across the health care landscape.
HIV-related immunosuppression may contribute to an elevated risk of cancer-related morbidity in elderly patients with the disease.
A study in the Bukoba municipality of Tanzania has suggested that scaling up HIV testing, improving linkages to HIV care, and strengthening retention of antiretroviral therapy interventions can help increase viral load suppression (VLS).
It is prudent for pharmacists to stay current with these therapies and prevention strategies, as they are well-positioned to educate and support patients in their illness.